Nutriband Inc (NTRB)
4.10
-0.17
(-3.98%)
USD |
NASDAQ |
Apr 18, 16:00
4.065
-0.04
(-0.85%)
After-Hours: 20:00
Nutriband Research and Development Expense (Quarterly): 0.5515M for Oct. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | 0.5515M |
| July 31, 2023 | 0.4451M |
| April 30, 2023 | 0.4004M |
| January 31, 2023 | 0.2958M |
| October 31, 2022 | 0.2907M |
| July 31, 2022 | 0.2779M |
| April 30, 2022 | 0.1178M |
| Date | Value |
|---|---|
| January 31, 2022 | 0.2504M |
| October 31, 2021 | 0.161M |
| July 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | 0.00 |
| October 31, 2020 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Oct 2020
0.5515M
Maximum
Oct 2023
0.2147M
Average
0.2504M
Median
Jan 2022
Research and Development Expense (Quarterly) Benchmarks
| Align Technology Inc | 82.16M |
| ThermoGenesis Holdings Inc | 0.329M |
| NeuroOne Medical Technologies Corp | 1.483M |
| SINTX Technologies Inc | 1.824M |
| enVVeno Medical Corp | 2.981M |